ABSTRACT

Keywords: nanotechnology, nanoscience, nanomedicine, nanobiotechnology, nanopharmaceutical, nanodrug, nanomaterial, Abbreviated New Drug Application (ANDA), patents, commercialization, technology transfer, research and development (R&D), US Food and Drug Administration (FDA), the European Medicines Agency (EMA), Environmental Protection Agency (EPA), Centers for Disease Control and Prevention (CDC), National Institute for Occupational Safety and Health (NIOSH), World Intellectual Property Organization (WIPO), US Patent and Trademark Office (PTO), International Organization for Standardization (ISO), American Society for Testing and Materials (ASTM) International, Organization for Economic Co-operation and Development (OECD), patent proliferation, nomenclature, regulatory definition, drug delivery, engineered nanotherapeutics, drug delivery systems (DDS), site-specific delivery, nanopotential, nanoscale, nanocharacter, nanodimensions, specific surface area (SSA), controlled manipulation, nanoparticles (NPs) 1What’s in a name? is a mystery short story by Isaac Asimov that appeared in the June 1956 issue of The Saint Detective Magazine under the title Death of a Honey-Blonde. Also see, Shakespeare’s Romeo and Juliet (Act 2, Scene 2): “What’s in a name? That which we call a rose by any other name would smell as sweet.”